BMT as initial treatment for severe aplastic anemia, macrophage metabolic rewiring in sickle cell disease, and predicting outcomes using PET radiomics in diffuse large B cell lymphoma
Blood Podcast
00:00
Clinical Pet: A Predictive Tool for DLBCL Patients
Clinical Pet remained predictive of outcomes in six independent, first-line DLBCL studies. The model exhibited better performance than the currently used IPI. For novel prognostic tools to be useful, all the components must not only be validated, but also widely available.
Transcript
Play full episode
